Literature DB >> 24601691

Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.

Shilpa Oak1, Lakshmi K Gaur, Jared Radtke, Roshni Patel, Dinakar Iyer, Nalini Ram, Ruchi Gaba, Ashok Balasubramanyam, Christiane S Hampe.   

Abstract

CONTEXT: Ketosis-prone diabetes (KPD), defined by presentation with diabetic ketoacidosis (DKA), comprises 4 subgroups based on the presence or absence of islet cell autoantibodies (A(-) or A(+)) and β-cell functional reserve (β(-) or β(+)). Among A(+) KPD, autoantibody epitope reactivity to 65-kDa glutamate decarboxylase (GAD65), defined by monoclonal GAD65Ab(DPD), was associated with greater β-cell functional reserve. In a majority of healthy individuals, GAD65Ab are present in the sera but are masked by anti-idiotypic antibodies; in contrast, overtly GAD65Ab-positive patients with autoimmune type 1 diabetes patients lack these anti-idiotypic antibodies.
OBJECTIVE: Our objective was to determine the presence of masked and overt GAD65Ab(DPD) in relation to β-cell function and genetic risk factors in KPD patients.
DESIGN: We investigated the associations of masked and overt GAD65Ab(DPD) with β-cell functional reserve, and their relationship with human leukocyte antigen (HLA) class II haplotypes linked to autoimmune diabetes susceptibility or resistance, in a large KPD cohort. PATIENTS: Adult KPD patients (n = 384) were followed longitudinally in a research clinic. MAIN OUTCOME MEASURES: β-Cell function, autoantibody status, GAD65Ab epitopes, and HLA class II haplotypes were evaluated.
RESULTS: Overall, KPD patients with β-cell functional reserve (β(+) subgroups) showed significantly higher frequency of masked GAD65Ab(DPD) than patients without β-cell functional reserve (β(-) subgroups): 112 of 144 (79%) compared with 59 of 100 (59%), respectively (P = .002). Masked or overt GAD65Ab(DPD) were also more frequent among autoantibody-positive patients with preserved β-cell functional reserve (A(+)β(+) KPD) than those lacking β-cell function (A(+)β(-) KPD): 77% compared with 55% (P = .01). The susceptibility HLA haplotypes DQA1*0301/DQB1*0302 and DQA1*0301/DQB1*0201 were associated with absence of overt or masked GAD65Ab(DPD) (odds Ratios 2.3 and 2.2, respectively).
CONCLUSIONS: Masked GAD65Ab(DPD) are strongly associated with preserved β-cell functional reserve among patients with KPD. Absence of GAD65Ab(DPD) reactivity is associated with 2 HLA class II susceptibility haplotypes for autoimmune type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24601691      PMCID: PMC4037721          DOI: 10.1210/jc.2013-4189

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  HLA-DQw3.2 allele of the DR4 haplotype is associated with insulin-dependent diabetes; correlation between DQ beta restriction fragments and DQ beta chain variation.

Authors:  D S Monos; R S Spielman; K J Gogolin; S F Radka; L Baker; C M Zmijewski; M Kamoun
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes.

Authors:  Jinko Graham; William A Hagopian; Ingrid Kockum; Lou Sheng Li; Carani B Sanjeevi; Robert M Lowe; Jonathan B Schaefer; Marjan Zarghami; Heather L Day; Mona Landin-Olsson; Jerry P Palmer; Marta Janer-Villanueva; Leroy Hood; Göran Sundkvist; Ake Lernmark; Norman Breslow; Gisela Dahlquist; Göran Blohmé
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

3.  Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.

Authors:  W A Hagopian; C B Sanjeevi; I Kockum; M Landin-Olsson; A E Karlsen; G Sundkvist; G Dahlquist; J Palmer; A Lernmark
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.

Authors:  P A Morel; J S Dorman; J A Todd; H O McDevitt; M Trucco
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.

Authors:  C F Verge; D Stenger; E Bonifacio; P G Colman; C Pilcher; P J Bingley; G S Eisenbarth
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

6.  Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response.

Authors:  John G Routsias; Eleni Dotsika; Eugenia Touloupi; Maria Papamattheou; Constantinos Sakarellos; Maria Sakarellos-Daitsiotis; Haralampos M Moutsopoulos; Athanasios G Tzioufas
Journal:  J Autoimmun       Date:  2003-08       Impact factor: 7.094

7.  Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4.

Authors:  G S Eisenbarth; S Srikanta; E Fleischnick; O P Ganda; R A Jackson; S J Brink; J S Soeldner; E J Yunis; C Alper
Journal:  Diabetes Care       Date:  1985 Sep-Oct       Impact factor: 19.112

8.  Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes.

Authors:  Mario Maldonado; Christiane S Hampe; Lakshmi K Gaur; Susana D'Amico; Dinakar Iyer; Lisa P Hammerle; Douglas Bolgiano; Lucille Rodriguez; Arun Rajan; Ake Lernmark; Ashok Balasubramanyam
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

9.  A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.

Authors:  C E Grubin; T Daniels; B Toivola; M Landin-Olsson; W A Hagopian; L Li; A E Karlsen; E Boel; B Michelsen; A Lernmark
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

10.  Islet-specific T-cell responses and proinflammatory monocytes define subtypes of autoantibody-negative ketosis-prone diabetes.

Authors:  Barbara M Brooks-Worrell; Dinakar Iyer; Ivonne Coraza; Christiane S Hampe; Ramaswami Nalini; Kerem Ozer; Radhika Narla; Jerry P Palmer; Ashok Balasubramanyam
Journal:  Diabetes Care       Date:  2013-10-15       Impact factor: 19.112

View more
  3 in total

1.  Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.

Authors:  An Goris; Ine Pauwels; Marte W Gustavsen; Brechtje van Son; Kelly Hilven; Steffan D Bos; Elisabeth Gulowsen Celius; Pål Berg-Hansen; Jan Aarseth; Kjell-Morten Myhr; Sandra D'Alfonso; Nadia Barizzone; Maurizio A Leone; Filippo Martinelli Boneschi; Melissa Sorosina; Giuseppe Liberatore; Ingrid Kockum; Tomas Olsson; Jan Hillert; Lars Alfredsson; Sahl Khalid Bedri; Bernhard Hemmer; Dorothea Buck; Achim Berthele; Benjamin Knier; Viola Biberacher; Vincent van Pesch; Christian Sindic; Annette Bang Oturai; Helle Bach Søndergaard; Finn Sellebjerg; Poul Erik H Jensen; Manuel Comabella; Xavier Montalban; Jennifer Pérez-Boza; Sunny Malhotra; Jeannette Lechner-Scott; Simon Broadley; Mark Slee; Bruce Taylor; Allan G Kermode; Pierre-Antoine Gourraud; Stephen J Sawcer; Bettina Kullle Andreassen; Bénédicte Dubois; Hanne F Harbo
Journal:  Brain       Date:  2015-01-22       Impact factor: 13.501

Review 2.  Precision medicine in diabetes: an opportunity for clinical translation.

Authors:  Jordi Merino; Jose C Florez
Journal:  Ann N Y Acad Sci       Date:  2018-01       Impact factor: 5.691

3.  DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.

Authors:  N Bansal; C S Hampe; L Rodriguez; E O'Brian Smith; J Kushner; A Balasubramanyam; M J Redondo
Journal:  Diabet Med       Date:  2016-02-12       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.